Movie 1 |
Movie 2 |
Control of Mtb infection within a well-circumscribed granuloma in the absence of TNF inhibitor |
Infection dynamics after granuloma treatment with etanercept at a small vascular permeability coefficient (kc = 1.1×10-8 cm/s) |
Movie 3 |
Movie 4 |
Infection dynamics after granuloma treatment with etanercept at a high vascular permeability coefficient (kc = 1.1×10-7 cm/s) |
Infection dynamics after granuloma treatment with infliximab at a small vascular permeability coefficient (kc = 1.1×10-8 cm/s) |
Movie 5 |
Movie 6 |
Infection dynamics after granuloma treatment with infliximab at a high vascular permeability coefficient (kc = 1.1×10-7 cm/s) |
The effect of pharmacokinetic fluctuations in the blood concentration of infliximab on infection dynamics for a small vascular permeability coefficient (kc = 1.1×10-8 cm/s) |
Movie 7 |
|
The effect of pharmacokinetic fluctuations in the blood concentration of infliximab on infection dynamics for a high vascular permeability coefficient (kc = 1.1×10-7 cm/s) |
[ Multiscale Anti-TNF Drugs Simulations Homepage | Kirschner Lab Time-Lapse Simulations Homepage ] |